Abstract
Complete immunological tolerance to sheep cells can be induced in mice when cyclophosphamide is injected together with sheep cells or up to 72 hr before or 48 hr after the antigen. As is true for radiation-induced immune suppression, the drug is most effective when given in the 24 hr prior to antigen. Complete cyclophosphamide-induced immunological suppression requires large doses of sheep cells (6.2 x 109 cells), presumably to enable antigen to reach sequestered receptor sites. The cyclophosphamide tolerance system has been analyzed with the Jerne technique to determine plaque-forming cells and with isotopic methods to measure rates of nucleic acid synthesis. This drug suppression has been found to consist of two components. The first is nonspecific injury to the lymphoid system caused by the cytotoxic drug and is related to the proportion of spleen cells killed. The second is antigen-specific immunological tolerance and appears to correlate with profound depression of deoxyribonucleic acid synthesis in the surviving cells. This tolerance is thought to be most consistent with a mechanism in which antigenic stimulation in the presence of cyclophosphamide-inhibited DNA synthesis and mitosis leads to the elimination or death of the specific immunological clone. Tolerance induction with cyclophosphamide is associated with loss of the 19S hemolysin plaques which are seen in nonstimulated mouse spleen, implicating these cells in immune responsiveness. The ability to induce tolerance is lost on the 3rd postantigen day at the end of a 24-hr period in which 19S cells have increased 8-fold and 7S cells 200-fold. The data suggest that loss of sensitivity is due to the emergence on day 3 of drug-resistant plaque-forming cells, particularly those of the 19S variety. In the succeeding days after antigen injection there is a progressive increase in the resistance of plaque-forming cells to cyclophosphamide administration.
Full Text
The Full Text of this article is available as a PDF (693.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADLER F. L. STUDIES ON MOUSE ANTIBODIES. I. THE RESPONSE TO SHEEP RED CELLS. J Immunol. 1965 Jul;95:26–38. [PubMed] [Google Scholar]
- AISENBERG A. C., WILES B. STUDIES ON THE SUPPRESSION OF IMMUNE RESPONSES BY THE PERIWINKLE ALKALOIDS VINCRISTINE AND VINBLASTINE. J Clin Invest. 1964 Dec;43:2394–2403. doi: 10.1172/JCI105114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aisenberg A. C., Wilkes B. Immunological tolerance induced by cyclophosphamide assayed by plaque spleen cell method. Nature. 1967 Feb 4;213(5075):498–499. doi: 10.1038/213498a0. [DOI] [PubMed] [Google Scholar]
- BERENBAUM M. C., BROWN I. N. DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE. Immunology. 1964 Jan;7:65–71. [PMC free article] [PubMed] [Google Scholar]
- BERENBAUM M. C. IMMUNOSUPPRESSIVE AGENTS. Br Med Bull. 1965 May;21:140–146. doi: 10.1093/oxfordjournals.bmb.a070382. [DOI] [PubMed] [Google Scholar]
- BERENBAUM M. C. The effect of cytotoxic agents on the production of antibody to T.A.B. vaccine in the mouse. Biochem Pharmacol. 1962 Jan;11:29–44. doi: 10.1016/0006-2952(62)90088-6. [DOI] [PubMed] [Google Scholar]
- BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DALGARNO L., MARTIN E. M. STUDIES ON EMC VIRAL RNA SYNTHESIS AND ITS LOCALIZATION IN INFECTED KREBS ASCITES CELLS. Virology. 1965 Jul;26:450–465. doi: 10.1016/0042-6822(65)90008-5. [DOI] [PubMed] [Google Scholar]
- Dresser D. W., Wortis D. H. Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency. Nature. 1965 Nov 27;208(5013):859–861. doi: 10.1038/208859a0. [DOI] [PubMed] [Google Scholar]
- Elion G. B., Hitchings G. H. Metabolic basis for the actions of analogs of purines and pyrimidines. Adv Chemother. 1965;2:91–177. doi: 10.1016/b978-1-4831-9930-6.50008-3. [DOI] [PubMed] [Google Scholar]
- FRISCH A. W., DAVIES G. H. INHIBITION OF HEMAGGLUTININ SYNTHESIS BY CYTOXAN. Cancer Res. 1965 Jun;25:745–751. [PubMed] [Google Scholar]
- HALPERN B. N., BIOZZI G., BENACERRAF B., STIFFEL C. Phagocytosis of foreign red blood cells by the reticulo-endothelial system. Am J Physiol. 1957 Jun;189(3):520–526. doi: 10.1152/ajplegacy.1957.189.3.520. [DOI] [PubMed] [Google Scholar]
- JERNE N. K. Immunological speculations. Annu Rev Microbiol. 1960;14:341–358. doi: 10.1146/annurev.mi.14.100160.002013. [DOI] [PubMed] [Google Scholar]
- JERNE N. K., NORDIN A. A. Plaque formation in agar by single antibody-producing cells. Science. 1963 Apr 26;140(3565):405–405. [PubMed] [Google Scholar]
- MITCHISON N. A. Tolerance of erythrocytes in poultry:induction and specificity. Immunology. 1962 May;5:341–358. [PMC free article] [PubMed] [Google Scholar]
- NATHAN H. C., BIEBER S., ELION G. B., HITCHINGS G. H. Detection of agents which interfere with the immune response. Proc Soc Exp Biol Med. 1961 Aug-Sep;107:796–799. doi: 10.3181/00379727-107-26758. [DOI] [PubMed] [Google Scholar]
- PHILIPS F. S., STERNBERG S. S., CRONIN A. P., VIDAL P. M. Cyclophosphamide and urinary bladder toxicity. Cancer Res. 1961 Dec;21:1577–1589. [PubMed] [Google Scholar]
- SCHWARTZ R., DAMESHEK W. Drug-induced immunological tolerance. Nature. 1959 Jun 13;183(4676):1682–1683. doi: 10.1038/1831682a0. [DOI] [PubMed] [Google Scholar]
- SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
- Sahiar K., Schwartz R. S. The immunoglobulin sequence. I. Arrest by 6-mercaptopurine and restitution by antibody, antigen or splenectomy. J Immunol. 1965 Aug;95(2):345–354. [PubMed] [Google Scholar]
- TALIAFERRO W. H., TALIAFERRO L. G. THE RELATION OF RADIATION DOSAGE TO ENHANCEMENT, DEPRESSION, AND RECOVERY OF THE INITIAL FORSSMAN HEMOLYSIN RESPONSE IN RABBITS. J Infect Dis. 1964 Oct;114:285–303. doi: 10.1093/infdis/114.4.285. [DOI] [PubMed] [Google Scholar]